Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. MK-7339-013

   Merck Sharp and Dohme

   Participants with Limited Stage-Small Cell Lung Cancer, who have received no prior anticancer therapy for their disease.

   phase 3 · small molecule · active

   1 trial →

2. MK2870-004

   Merck Sharp and Dohme

   Non-small Cell Lung Cancer (NSCLC)

   phase 3 · small molecule · active

   1 trial →

3. MK3475-054

   Merck Sharp and Dohme

   Stage III melanoma (AJCC R0) with histologically confirmed cutaneous melanoma metastatic to lymph node, classified as (AJCC, 2010): Stage IIIA with metastasis > 1 mm; any Stage IIIB or IIIC (no in-transit metastases)

   phase 3 · small molecule · active

   1 trial →

4. MK3475-859

   Merck Sharp and Dohme

   Gastric and gastric esophageal junction (GEJ) adenocarcinoma

   phase 3 · small molecule · active

   1 trial →

5. MK3475-B15

   Merck Sharp and Dohme

   Muscle Invasive Bladder Cancer

   phase 3 · small molecule · active

   1 trial →

6. ML42502

   Hoffmann-La Roche

   HER2-POSITIVE EARLY BREAST CANCER

   phase 3 · small molecule · active

   1 trial →

7. MO29406

   Hoffmann-La Roche

   Solid Malignant Tumors

   phase 3 · small molecule · active

   1 trial →

8. MO29872

   Hoffmann-La Roche

   Non-Small Cell Lung Cancer

   phase 3 · small molecule · completed

   1 trial →

9. MO40598

   Hoffmann-La Roche

   Relapsed/refractory diffuse large B-cell lymphoma (DLBCL)

   phase 3 · small molecule · active

   1 trial →

10. MO41552

    Hoffmann-La Roche

    Non-small cell lung cancer with ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) gene rearrangements

    phase 3 · small molecule · active

    1 trial →

11. MO43110

    Hoffmann-La Roche

    Early Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

12. MO43110

    Hoffmann-La Roche

    Early or Locally Advanced/ Inflammatory HER2-Positive Breast Cancer

    phase 3 · small molecule · active

    1 trial →

13. MOR208C310

    Incyte

    Newly-diagnosed high-intermediate and high-risk diffuse large B-cell lymphoma (DLBCL)

    phase 3 · small molecule · active

    1 trial →

14. MRI

    United Therapeutics Europe Ltd

    Prostate Neoplasm

    phase 3 · other · completed

    1 trial →

15. MTX

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gestational Trophoblastic Tumor

    phase 3 · small molecule · active

    1 trial →

16. Medpulser Electroporation with Bleomycin

    INOVIO PHARMACEUTICALS, INC.

    Head Neck Cancer

    phase 3 · other · terminated

    1 trial →

17. Megestrol（Yining）

    The First People's Hospital of Lianyungang

    Stage III Esophageal Squamous Cell Carcinoma

    phase 3 · small molecule · completed

    1 trial →

18. Methylthioninium

    Shandong Suncadia Medicine Co.,

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

19. MiLES

    Turn Therapeutics

    Cancer

    phase 3 · other · active

    1 trial →

20. Mirvetuximab Soravtansine

    AbbVie

    Epithelial Ovarian Cancer

    phase 3 · small molecule · completed

    1 trial →

21. Mirvetuximab soravtansine plus Bevacizumab

    AbbVie

    Ovarian Cancer

    phase 3 · small molecule · active

    1 trial →

22. Mitoxantrone Hydrochloride Liposome

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia (AML)

    phase 3 · small molecule · active

    1 trial →

23. Motesanib

    Takeda

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · terminated

    1 trial →

24. Myocet

    Teva Pharma GmbH

    Early Primary Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

25. NDV-01 (sustained-release gemcitabine-docetaxel)

    RELMADA THERAPEUTICS, INC.

    Bladder (Urothelial, Transitional Cell) Cancer

    phase 3 · small molecule · active

    2 trials →

26. NDV-01 (sustained-release gemcitabine-docetaxel)

    RELMADA THERAPEUTICS, INC.

    Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)

    phase 3 · small molecule · terminated

    1 trial →

27. NGAM-12

    Maze Therapeutics

    Primary infection prophylaxis in patients with chronic lymphocytic leukemia (CLL) and secondary hypogammaglobulinemia.

    phase 3 · small molecule · active

    1 trial →

28. NHL-014

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diffuse Large B-Cell Lymphoma

    phase 3 · small molecule · active

    1 trial →

29. NIS793

    Novartis Pharmaceuticals

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 3 · small molecule · completed

    1 trial →

30. NIVOLUMAB for Advanced MET exon 14 Mutated Non-Small Cell Lung Cancer

    CERO THERAPEUTICS HOLDINGS, INC.

    Advanced MET exon 14 Mutated Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

31. NKTR-102

    Nektar Therapeutics UK Limited

    Locally Recurrent Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

32. NKTR-214

    Nektar Therapeutics UK Limited

    Melanoma

    phase 3 · mab · completed

    1 trial →

33. NKTR-214

    Bristol-Myers Squibb

    Melanoma

    phase 3 · mab · completed

    1 trial →

34. NKTR-255 at 1.5 µg/kg

    Nektar Therapeutics UK Limited

    Non-Hodgkin Lymphoma

    phase 3 · small molecule · terminated

    1 trial →

35. NRG-GY019

    Ningbo Cancer Hospital

    low-grade serous carcinoma of the ovary or peritoneum

    phase 3 · small molecule · active

    1 trial →

36. NUBEQA film-coated tablets for Localised Very High-Risk Cancer of the Prostate

    Ningbo Cancer Hospital

    Localised Very High-Risk Cancer of the Prostate

    phase 3 · small molecule · active

    1 trial →

37. NX-5948

    Nurix Therapeutics

    B-cell Lymphoma

    phase 3 · small molecule · active

    2 trials →

38. Nab-paclitaxel 80 mg/m^2

    CORCEPT THERAPEUTICS INC

    Ovarian Neoplasm

    phase 3 · small molecule · active

    1 trial →

39. Nadroparin, long term

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    phase 3 · small molecule · active

    1 trial →

40. Namodenoson

    Can-Fite BioPharma

    Hepatocellular Carcinoma

    phase 3 · small molecule · active

    1 trial →

41. Nano-crystalline Megestrol Acetate Oral Suspension

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Extensive-stage Small Cell Lung Cancer (ES-SCLC)

    phase 3 · small molecule · active

    1 trial →

42. Napabucasin

    Sumitomo Pharma (Suzhou) Co.,

    Carcinoma, Pancreatic Ductal

    phase 3 · small molecule · completed

    1 trial →

43. Necitumumab

    Eli Lilly and Company

    Non Small Cell Lung Cancer

    phase 3 · mab · completed

    1 trial →

44. Nedaplatin

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 3 · small molecule · completed

    1 trial →

45. Nemtabrutinib

    Merck KGaA, Darmstadt, Germany

    Chronic Lymphocytic Leukemia

    phase 3 · small molecule · active

    1 trial →

46. Nilotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Myeloid Leukemia, Chronic Phase

    phase 3 · small molecule · active

    1 trial →

47. Nilotinib

    Novartis Pharmaceuticals

    Chronic Myeloid Leukemia

    phase 3 · small molecule · completed

    1 trial →

48. Nilotinib (AMN107)

    Novartis Pharmaceuticals

    Gastrointestinal Stromal Tumor (GIST)

    phase 3 · small molecule · completed

    1 trial →

Frequently asked questions